PBK and cancer: As the prognosis of stage 3 breast cancer patients was worse than those of patients in stages 1 and 2, the high expression of PBK/TOPK indicated that it was associated with the proliferation of malignant tumors and tumor progression, which was consistent with the existing evidence [25].